PWML: MRI-based Biomarkers for Predicting Punctate White Matter Lesions in Neonates

Sponsor
First Affiliated Hospital Xi'an Jiaotong University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02637817
Collaborator
Shenzhen Children's Hospital (Other), General Hospital of Ningxia Medical University (Other), Xijing Hospital (Other), Shengjing Hospital (Other), Second Affiliated Hospital of Wenzhou Medical University (Other), Zunyi Medical College (Other), Shaanxi Provincial People's Hospital (Other), Baoji Central Hospital (Other), Children's Hospital of Fudan University (Other), Hainan People's Hospital (Other)
600
1
47
12.8

Study Details

Study Description

Brief Summary

As a common white matter (WM) disease in preterm neonates, punctate white matter lesion (PWML) frequently leads to the abnormalities of brain development (e.g. the motor, visual and auditory disorders), even to cerebral palsy (CP) and amblyopia during childhood. However, it is lack of certain methods in identifying the prognosis of PWML. Through using various advanced MRI techniques, neuro-behavioral and visual assessments, a multicenter longitudinal study would be conducted to follow-up the PWML neonates with varying spatial-position and degree lesions. Through tracking the variations in WM microstructures from neonate period to childhood (2 years old and 3 years old), this study aims to explore (1) the potential relations between varying PWMLs and motor and visual disorders (2) the relations between WM MRI-metrics and neurodevelopmental assessment results, and thus determine the early biomarkers to identify CP and amblyopia.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    600 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    MRI-based Biomarkers for the Prognosis Judgement of Punctate White Matter Lesions in Neonates: a Longitudinal Multicenter Study
    Study Start Date :
    Jan 1, 2016
    Anticipated Primary Completion Date :
    Jun 1, 2019
    Anticipated Study Completion Date :
    Dec 1, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    Control Group

    Neonates with no evidence of brain lesions on conventional MRI.

    Patients Group

    Neonates with PWML diagnosed by conventional MRI.

    Outcome Measures

    Primary Outcome Measures

    1. Cerebral Palsy [At age 2]

      The enrolled subjects who will be diagnosed as cerebral palsy by clinical examination at age 2.

    Secondary Outcome Measures

    1. Amblyopia or movement disorder [At age 3]

      The enrolled subjects who will be diagnosed as amblyopia or movement disorder by clinical examination at age 3.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Day to 28 Days
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    -(1) Age: 1-28 days (2) PWML (3) High quality MRI scan

    Exclusion Criteria:

    -(1) Congenital malformations, infections, metabolic disorders, intraventricular hemorrhage (2) Neonates of mothers with gestational diabetes, hypertension, hypoglycemia and history of alcohol

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 First Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi China

    Sponsors and Collaborators

    • First Affiliated Hospital Xi'an Jiaotong University
    • Shenzhen Children's Hospital
    • General Hospital of Ningxia Medical University
    • Xijing Hospital
    • Shengjing Hospital
    • Second Affiliated Hospital of Wenzhou Medical University
    • Zunyi Medical College
    • Shaanxi Provincial People's Hospital
    • Baoji Central Hospital
    • Children's Hospital of Fudan University
    • Hainan People's Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    First Affiliated Hospital Xi'an Jiaotong University
    ClinicalTrials.gov Identifier:
    NCT02637817
    Other Study ID Numbers:
    • 2016YFC0100300
    First Posted:
    Dec 22, 2015
    Last Update Posted:
    Jun 28, 2018
    Last Verified:
    Jun 1, 2018

    Study Results

    No Results Posted as of Jun 28, 2018